FDA Approvals

ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease

Endpoints News 1h ago FDA Approval

UpDoc, Tempus AI and Atman Health will participate in a new program that aims to build FDA-authorized agentic AI tools to care for people with heart disease, the federal government announced Wednesday. Called ADVOCATE, the ...

Discussion

Sign in to join the discussion. Comments loading…